American Journal of Ophthalmology
Volume 142, Issue 6 , Pages 976-982.e4 , December 2006

Trends in Cost of Major Eye Diseases to Medicare, 1991 to 2000

  • Martin Salm, MA

      Affiliations

    • University of Mannheim, Institute for the Economics of Aging, Mannheim, Germany
    • ,
  • Daniel Belsky, BA

      Affiliations

    • Duke University Center for Health Policy, Durham, North Carolina.
    • ,
  • Frank A. Sloan, PhD

      Affiliations

    • Duke University Center for Health Policy, Durham, North Carolina.
    • Corresponding Author InformationInquiries to Frank A. Sloan, PhD, Box 90253, 114 Rubenstein Hall, Center for Health Policy, Duke University, Durham, NC 27708

,Accepted 28 July 2006.

References 

  1. Javitt JC, Chiang YP. Preparing for managed competition: utilization of ambulatory eye care visits to ophthalmologists. Arch Ophthalmol. 1993;111:1034–1035
  2. Boards of Trustees. Federal Hospital Insurance and Federal Supplementary Medical Insurance Trust Funds (2005 Annual Report of the Boards of Trustees, Federal Hospital Insurance and Federal Supplementary Medical Insurance Trust Funds). 2006;URL: http://www.cms.hhs.gov/ReportsTrustFunds/downloads/tr2005.pdf. Access Date: August 15
  3. Seshamani M, Gray A. Health care expenditures and aging: an international comparison. Appl Health Econ Health Policy. 2003;2:9–16
  4. Stearns SC, Norton EC. Time to include time to death? (The future of health care expenditure predictions). Health Econ. 2004;13:315–327
  5. Steinman L, Tesler H, Zweifel P. The impact of aging on future healthcare expenditure. 2005;Working paper 0510, Socioeconomic Institute, University of Zurich, Forthcoming
  6. Zweifel P, Felder S, Meiers M. Aging of population and health care expenditure: a red herring?. Health Econ. 1999;8:485–496
  7. Steinberg EP, Bergner M, Sommer A, et al. Variations in cataract management: patient and economic outcomes. Health Serv Res. 1990;25:727–731
  8. Javitt JC, Canner JK, Sommer A. Cost-effectiveness of current approaches to the control of retinopathy in type I diabetics. Ophthalmology. 1989;96:255–264
  9. Javitt JC, Aiello PL, Chiang Y, Ferris FL, Canner JK, Greenfield S. Preventive eye care in people with diabetes is cost-saving to the federal government (Implications for health-care reform). Diabetes Care. 1994;17:909–917
  10. Frenkel M. Analysis of ophthalmic surgical charges for services to Medicare recipients: 1980–1985. Arch Ophthalmol. 1989;107:1132–1134
  11. Bernth-Petersen P. Outcome of cataract surgery, IV: socio-economic aspects. Acta Ophthalmol (Copenh). 1982;60:461–468
  12. Bonastre J, Le Pen C, Soubrane G, Quentel G. The burden of age-related macular degeneration: results of a cohort study in two French referral centers. Pharmacoeconomics. 2003;21:181–190
  13. Calissendorff BM. Costs of medical and surgical treatment of glaucoma. Acta Ophthalmol Scand. 2001;79:286–288
  14. Iskedjian M, Walker J, Civente C, et al. Cost of glaucoma in Canada: analysis based on visual field and physician’s assessment. J Glaucoma. 2003;12:456–462
  15. Kobelt G, Jönsson L. Modeling cost of treatment with new topical treatments for glaucoma: results from France and the United Kingdom. Int J Technol Assess Health Care. 1999;15:207–219
  16. Kobelt-Nguyen G, Gerdtham UG, Alm A. Costs of treating primary open-angle glaucoma and ocular hypertension: a retrospective, observational two-year chart review of newly diagnosed patients in Sweden and the United States. J Glaucoma. 1998;7:95–104
  17. Matz H, Falk M, Gottinger W, Kieselbach G. Cost-benefit analysis of diabetic eye disease. Opthalmologica. 1996;210:348–353
  18. Chou SL, Misajon R, Gallo J, Keeffe JE. Measurement of indirect costs for people with vision impairment. Clin Exp Ophthalmol. 2003;31:336–340
  19. Meads C, Hyde C. What is the cost of blindness?. Br J Ophthalmol. 2003;87:1201–1204
  20. Muralikrishnan R, Venkatesh R, Prajna NV, Frick KD. Economic cost of cataract surgery procedures in an established eye care centre in Southern India. Ophthalmic Epidemiol. 2004;11:369–380
  21. Oostenbrink JB, Rutten-van Molken MP, Sluyter-Openoordt TS. Resource use and costs of patients with glaucoma or ocular hypertension: a one-year study based on retrospective chart review in the Netherlands. J Glaucoma. 2001;10:184–191
  22. Smith AF. The economic impact of ophthalmic services for persons with diabetes in the Canadian province of Nova Scotia: 1996–1996. Ophthalmic Epidemiol. 2001;8:13–25
  23. Wang J, Chew PT. What is the direct cost of treatment of primary angle closure glaucoma? (The Singapore model). Clin Exp Opthalmol. 2004;32:578–583
  24. American Medical Association. Current procedural terminology, 1991 (CPT 1991). Chicago, Illinois: American Medical Association Press; 1990;
  25. American Medical Association. Current procedural terminology, 1995 (CPT 1995). Chicago, Illinois: American Medical Association Press; 1994;
  26. American Medical Association. Current procedural terminology, 1996 (CPT 1996). Chicago, Illinois: American Medical Association Press; 1995;
  27. American Medical Association. Current procedural terminology, Professional Edition, 1997 (CPT 1997). Chicago, Illinois: American Medical Association Press; 1996;
  28. American Medical Association. Current procedural terminology, Professional Edition,1998 (CPT 1998). Chicago, Illinois: American Medical Association Press; 1997;
  29. American Medical Association. Current procedural terminology, Professional Edition,1999 (CPT 1999). Chicago, Illinois: American Medical Association Press; 1998;
  30. American Medical Association. International classification of diseases, 9th revision, clinical modification, 1983 (ICD-CM 1983). Chicago, Illinois: American Medical Association Press; 1982;
  31. American Medical Association. International classification of diseases, 9th revision, clinical modification, 1999 (ICD-CM 1999). Chicago, Illinois: American Medical Association Press; 1998;
  32. American Medical Association. International classification of diseases, 9th revision, clinical modification, 1998 (ICD-CM 1998). Chicago, Illinois: American Medical Association Press; 1997;
  33. Raghunathan TE, Lepowski JM, Solenberger PW, et al. A multivariate technique for multiply imputing missing values using a sequence of regression models. Surv Methodol. 2001;27:85–95
  34. Raghunathan TE, Solenberger PW, van Hoewyk J. IVEware: imputation and variance estimation software user guide. Ann Arbor, Michigan: University of Michigan, Survey Research Center, Institute for Social Research; 2002;
  35. American Medical Association. Medicare RBRVS: The physicians’ guide, 1995. Chicago, Illinois: American Medical Association Press; 1994;
  36. American Medical Association. Medicare RBRVS: the physicians’ guide, 1999. Chicago, Illinois: American Medical Association Press; 1998;
  37. Brechner RJ, Cowie CC, Howie LJ, et al. Ophthalmic examination among adults with diagnosed diabetes mellitus. JAMA. 1993;270:1714–1718
  38. Martin TL, Zhang D, Selby J. Physician and patient prevention practices in NIDDM in a large urban managed-care organization. Diabetes Care. 1995;18:1124–1132
  39. Wylie-Rosett J, Basch C, Walker EA, et al. Ophthalmic referral rates for patients with diabetes in primary-care clinics located in disadvantaged urban communities. J Diabetes Complications. 1995;9:49–54
  40. Steinberg EP, Javitt JC, Sharkey PD, et al. The content and cost of cataract surgery. Arch Ophthalmol. 1993;111:1041–1049
  41. Chiang YP, Bassi LJ, Javitt JC. Federal budgetary costs of blindness. Milbank Q. 1992;70:319–340
  42. Sloan FA, Ostermann J, Brown DS, Lee PP. Effects of changes in self-reported vision on cognitive, affective, and functional status and living arrangements among the elderly. Am J Ophthalmol. 2005;140:618–627
  43. Ellis RP, Pope GC, Iezzoni L, et al. Diagnosis-based risk adjustment for Medicare capitation payments. Health Care Financ Rev. 1996;17:101–128
  44. Shapiro I, Shapiro MD, Wilcox D. Measuring the value of cataract surgery. In:  Cutler DM,  Berndt ER editor. Medical care: output and productivity. Chicago, Illinois: University of Chicago Press; 2001;p. 411–437

 Supplemental Material available at AJO.com.

PII: S0002-9394(06)00910-X

doi: 10.1016/j.ajo.2006.07.057

American Journal of Ophthalmology
Volume 142, Issue 6 , Pages 976-982.e4 , December 2006

Article Tools